Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases

Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases

Elevated markers of neuroinflammation have been found to be associated with many psychiatric and neurodegenerative diseases, such as mood disorders, Alzheimer's disease, and multiple sclerosis. Since neuroinflammation is thought to contribute to the pathophysiology of these diseases and to impa...

Full description

Bibliographic Details
Main Author:	Eleonore eBeurel
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2011-08-01
Series:	Frontiers in Molecular Neuroscience
Subjects:	Cytokines Inflammation Mood Disorders Multiple Sclerosis Neurodegenerative Diseases EAE
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fnmol.2011.00018/full

Similar Items

Possible Correlation between Cholinergic System Alterations and Neuro/Inflammation in Multiple Sclerosis
by: Valentina Gatta, et al.
Published: (2020-06-01)

Developmental ablation of mature oligodendrocytes exacerbates adult CNS demyelination
by: Ahdeah Pajoohesh-Ganji, et al.
Published: (2020-08-01)

Brain micro-inflammation at specific vessels dysregulates organ-homeostasis via the activation of a new neural circuit
by: Yasunobu Arima, et al.
Published: (2017-08-01)

The role of glycogen synthase kinase 3 beta in multiple sclerosis
by: Tayebeh Noori, et al.
Published: (2020-12-01)

Oleacein Attenuates the Pathogenesis of Experimental Autoimmune Encephalomyelitis through Both Antioxidant and Anti-Inflammatory Effects
by: Beatriz Gutiérrez-Miranda, et al.
Published: (2020-11-01)

T cell mediated pathogenesis in EAE: Molecular mechanisms
by: Florian C Kurschus
Published: (2015-06-01)

Effects of central and peripheral inflammation on hippocampal synaptic plasticity
by: Massimiliano Di Filippo, et al.
Published: (2013-04-01)

Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation
by: Suzanne A. B. M. Aarts, et al.
Published: (2017-05-01)

Iron deposition and inflammation in multiple sclerosis. Which one comes first?
by: Weinstock-Guttman Bianca, et al.
Published: (2011-06-01)

Central Nervous System Proteomics in Animal Model of Multiple Sclerosis Revealed Down-Regulation of Mithochondrial Proteins
by: Abolhassan Shahzadeh Fazeli, et al.
Published: (2009-01-01)

Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-κB signaling
by: Dangfeng Zhang, et al.
Published: (2020-05-01)

The role of the blood–CNS barrier in CNS disorders and their treatment
by: Alan M. Palmer
Published: (2010-01-01)

Macrophage Plasticity and Polarization Are Altered in the Experimental Model of Multiple Sclerosis
by: Alessandro Leuti, et al.
Published: (2021-06-01)

The role of the lung in shaping CNS autoimmunity
by: Hosang, Leon
Published: (2019)

Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model
by: Anna T. Wilmes, et al.
Published: (2018-06-01)

IL-10-differentiated dendritic cells treatment for Experimental Autoimmune Encephalomyelitis (EAE), a model of human Multiple Sclerosis
by: Xie, Siyuan
Published: (2010)

p38 MAP Kinase Signaling in Microglia Plays a Sex-Specific Protective Role in CNS Autoimmunity and Regulates Microglial Transcriptional States
by: Mahalia M. McGill, et al.
Published: (2021-10-01)

STEAP4 expression in CNS resident cells promotes Th17 cell-induced autoimmune encephalomyelitis
by: Junjie Zhao, et al.
Published: (2021-04-01)

Neuroprotection antiinflammatoire et antiischémique par modulation du protéasome
by: Hosseini, Hassan
Published: (2010)

Human Gut-Derived Commensal Bacteria Suppress CNS Inflammatory and Demyelinating Disease
by: Ashutosh Mangalam, et al.
Published: (2017-08-01)

The Nod-like receptor, Nlrp12, plays an anti-inflammatory role in experimental autoimmune encephalomyelitis
by: Mohammadi Mahvelati, Tara
Published: (2017)

Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis
by: Müller André, et al.
Published: (2012-03-01)

IFN-β Acts on Monocytes to Ameliorate CNS Autoimmunity by Inhibiting Proinflammatory Cross-Talk Between Monocytes and Th Cells
by: Javad Rasouli, et al.
Published: (2021-06-01)

The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease?
by: Hannah M. Kohl, et al.
Published: (2020-08-01)

Epidemiological Features of 263 Patients with Multiple Sclerosis Residing in ‎Babol, Iran
by: SMM Hojati, et al.
Published: (2016-01-01)

Glycogen synthase kinase-3 in the etiology and treatment of mood disorders
by: Richard Scott Jope
Published: (2011-08-01)

Mood Disorder as the Presenting Manifestation of Demyelination
by: D. Tapos, et al.
Published: (2013-05-01)

Regulation of Cell Survival Mechanisms in Alzheimer's Disease by Glycogen Synthase Kinase-3
by: Marjelo A. Mines, et al.
Published: (2011-01-01)

Type I Interferons as ambiguous modulators of chronic inflammation in the Central Nervous System
by: Marco ePrinz, et al.
Published: (2012-04-01)

The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic Inflammation
by: Fabian Richter, et al.
Published: (2021-07-01)

Gene Expression Analysis of Astrocyte and Microglia Endocannabinoid Signaling during Autoimmune Demyelination
by: Álvaro Moreno-García, et al.
Published: (2020-08-01)

The Emerging Role of Neutrophil Granulocytes in Multiple Sclerosis
by: Tonia Woodberry, et al.
Published: (2018-12-01)

CD8+ T cells as immune regulators of multiple sclerosis
by: Sushmita eSinha, et al.
Published: (2015-12-01)

FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models
by: Ranjithkumar Rajendran, et al.
Published: (2021-04-01)

Exploring the Gut-Brain Axis for the Control of CNS Inflammatory Demyelination: Immunomodulation by Bacteroides fragilis’ Polysaccharide A
by: Deniz Erturk-Hasdemir, et al.
Published: (2021-05-01)

A co-ultramicronized palmitoylethanolamide/luteolin composite mitigates clinical score and disease-relevant molecular markers in a mouse model of experimental autoimmune encephalomyelitis
by: Gabriella Contarini, et al.
Published: (2019-06-01)

Early IFNγ-Mediated and Late Perforin-Mediated Suppression of Pathogenic CD4 T Cell Responses Are Both Required for Inhibition of Demyelinating Disease by CNS-Specific Autoregulatory CD8 T Cells
by: Alexander W. Boyden, et al.
Published: (2018-10-01)

Multiple Sclerosis and the Endogenous Opioid System
by: Zoë Dworsky-Fried, et al.
Published: (2021-09-01)

Optic neuritis and retinal ganglion cell loss in a chronic murine model of multiple sclerosis
by: Thomas eQuinn, et al.
Published: (2011-08-01)

Changes of B cell subsets in central pathological process of autoimmune encephalomyelitis in mice
by: Yingqiong Xiong, et al.
Published: (2019-07-01)